{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:11:07Z","timestamp":1793970667286,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000121","name":"NSF | Directorate for Mathematical & Physical Sciences | Division of Mathematical Sciences","doi-asserted-by":"publisher","award":["1902854"],"award-info":[{"award-number":["1902854"]}],"id":[{"id":"10.13039\/100000121","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1055214"],"award-info":[{"award-number":["1055214"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1123673"],"award-info":[{"award-number":["1123673"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1055214"],"award-info":[{"award-number":["1055214"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1136322"],"award-info":[{"award-number":["1136322"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1149990"],"award-info":[{"award-number":["1149990"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41590-021-01113-x","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T12:03:30Z","timestamp":1642075410000},"page":"210-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":951,"title":["Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-5995","authenticated-orcid":false,"given":"Chansavath","family":"Phetsouphanh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9721-101X","authenticated-orcid":false,"given":"David R.","family":"Darley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6419-142X","authenticated-orcid":false,"given":"C. Mee Ling","family":"Munier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-1017","authenticated-orcid":false,"given":"Jennifer A.","family":"Juno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1863-7539","authenticated-orcid":false,"given":"Louise M.","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-4891","authenticated-orcid":false,"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0009-3337","authenticated-orcid":false,"given":"Anthony D.","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"1113_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre, C. H. et al. Attributes and predictors of long COVID. Nat. Med. 27, 626\u2013631 (2021).","journal-title":"Nat. Med."},{"key":"1113_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J. & Prescott, H. C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324, 782\u2013793 (2020).","journal-title":"JAMA"},{"key":"1113_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","volume":"21","author":"T Carvalho","year":"2021","unstructured":"Carvalho, T., Krammer, F. & Iwasaki, A. The first 12 months of COVID-19: a timeline of immunological insights. Nat. Rev. Immunol. 21, 245\u2013256 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1113_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1113_CR5","doi-asserted-by":"publisher","unstructured":"Peluso, M. J., et al. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection\/COVID-19. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.03.11.21252311 (2021).","DOI":"10.1101\/2021.03.11.21252311"},{"key":"1113_CR6","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","volume":"169","author":"MH Lam","year":"2009","unstructured":"Lam, M. H. et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch. Intern. Med. 169, 2142\u20132147 (2009).","journal-title":"Arch. Intern. Med."},{"key":"1113_CR7","first-page":"jrm00063","volume":"52","author":"H Ahmed","year":"2020","unstructured":"Ahmed, H. et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J. Rehabil. Med 52, jrm00063 (2020).","journal-title":"J. Rehabil. Med"},{"key":"1113_CR8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jmv.26368","volume":"93","author":"SJ Halpin","year":"2021","unstructured":"Halpin, S. J. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med Virol. 93, 1013\u20131022 (2021).","journal-title":"J. Med Virol."},{"key":"1113_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5694\/mja2.50963","volume":"214","author":"DR Darley","year":"2021","unstructured":"Darley, D. R. et al. Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection. Med J. Aust. 214, 279\u2013280 (2021).","journal-title":"Med J. Aust."},{"key":"1113_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0140-6736(21)00039-8","volume":"397","author":"M Cortinovis","year":"2021","unstructured":"Cortinovis, M., Perico, N. & Remuzzi, G. Long-term follow-up of recovered patients with COVID-19. Lancet 397, 173\u2013175 (2021).","journal-title":"Lancet"},{"key":"1113_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 220\u2013232 (2021).","journal-title":"Lancet"},{"key":"1113_CR12","doi-asserted-by":"publisher","unstructured":"Sudre, C. H., et al. Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.12.15.20248096 (2020).","DOI":"10.1101\/2020.12.15.20248096"},{"key":"1113_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.15585\/mmwr.mm6926e3","volume":"69","author":"MW Tenforde","year":"2020","unstructured":"Tenforde, M. W. et al. Characteristics of adult outpatients and inpatients with COVID-19 - 11 academic medical centers, United States, March-May 2020. MMWR Morb. Mortal. Wkly Rep. 69, 841\u2013846 (2020).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"1113_CR14","doi-asserted-by":"publisher","first-page":"00384","DOI":"10.1183\/23120541.00384-2021","volume":"7","author":"D Darley","year":"2021","unstructured":"Darley, D. et al. Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort. ERJ Open Res. 7, 00384\u20132021 (2021).","journal-title":"ERJ Open Res."},{"key":"1113_CR15","doi-asserted-by":"publisher","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","volume":"11","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon, S. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis.Sci. Rep. 11, 16144 (2021).","journal-title":"Sci. Rep."},{"key":"1113_CR16","doi-asserted-by":"publisher","first-page":"2003730","DOI":"10.1183\/13993003.03730-2020","volume":"57","author":"SK Patel","year":"2021","unstructured":"Patel, S. K. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences.Eur. Respir. J. 57, 2003730 (2021).","journal-title":"Eur. Respir. J."},{"key":"1113_CR17","doi-asserted-by":"crossref","unstructured":"Dunn, P. K. Log-linear models. In Encyclopedia of Social Measurement (Ed. Kempf-Leonard, K.) 585\u2013589 (Elsevier, 2005).","DOI":"10.1016\/B0-12-369398-5\/00419-9"},{"key":"1113_CR18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","volume":"369","author":"A Broggi","year":"2020","unstructured":"Broggi, A. et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 369, 706\u2013712 (2020).","journal-title":"Science"},{"key":"1113_CR19","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"1113_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.abc2061","volume":"369","author":"J Major","year":"2020","unstructured":"Major, J. et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science 369, 712\u2013717 (2020).","journal-title":"Science"},{"key":"1113_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaci.2020.09.007","volume":"147","author":"T Ueland","year":"2021","unstructured":"Ueland, T. et al. Elevated plasma sTIM-3 levels in patients with severe COVID-19. J. Allergy Clin. Immunol. 147, 92\u201398 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1113_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"1113_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bjid.2020.07.011","volume":"24","author":"C Portela Sousa","year":"2020","unstructured":"Portela Sousa, C. & Brites, C. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III. Braz. J. Infect. Dis. 24, 428\u2013433 (2020).","journal-title":"Braz. J. Infect. Dis."},{"key":"1113_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1089\/jir.2015.0169","volume":"36","author":"A Kelly","year":"2016","unstructured":"Kelly, A. et al. Immune cell profiling of IFN-lambda response shows pDCs express highest level of IFN-lambdaR1 and are directly responsive via the JAK-STAT pathway. J. Interferon Cytokine Res. 36, 671\u2013680 (2016).","journal-title":"J. Interferon Cytokine Res."},{"key":"1113_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.108.806547","volume":"120","author":"GD Norata","year":"2009","unstructured":"Norata, G. D. et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 120, 699\u2013708 (2009).","journal-title":"Circulation"},{"key":"1113_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1253\/circj.CJ-13-0329","volume":"78","author":"S Kimura","year":"2014","unstructured":"Kimura, S. et al. Relationships of elevated systemic pentraxin-3 levels with high-risk coronary plaque components and impaired myocardial perfusion after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction. Circ. J. 78, 159\u2013169 (2014).","journal-title":"Circ. J."},{"key":"1113_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-020-00832-x","volume":"22","author":"E Brunetta","year":"2021","unstructured":"Brunetta, E. et al. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat. Immunol. 22, 19\u201324 (2021).","journal-title":"Nat. Immunol."},{"key":"1113_CR28","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka, T., Narazaki, M. & Kishimoto, T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 6, a016295 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1113_CR29","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/jmv.25900","volume":"92","author":"FA Lagunas-Rangel","year":"2020","unstructured":"Lagunas-Rangel, F. A. & Chavez-Valencia, V. High IL-6\/IFN-gamma ratio could be associated with severe disease in COVID-19 patients. J. Med Virol. 92, 1789\u20131790 (2020).","journal-title":"J. Med Virol."},{"key":"1113_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1164\/rccm.202005-1701LE","volume":"202","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. COVID-19 severity correlates with weaker T-cell immunity, hypercytokinemia, and lung epithelium injury. Am. J. Respir. Crit. Care Med 202, 606\u2013610 (2020).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"1113_CR31","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1126\/science.abc8511","volume":"369","author":"D Mathew","year":"2020","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. Science 369, 6508 (2020).","journal-title":"Science"},{"key":"1113_CR32","doi-asserted-by":"publisher","first-page":"100208","DOI":"10.1016\/j.xcrm.2021.100208","volume":"2","author":"M Koutsakos","year":"2021","unstructured":"Koutsakos, M. et al. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep. Med 2, 100208 (2021).","journal-title":"Cell Rep. Med"},{"key":"1113_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1365-2567.1997.00258.x","volume":"91","author":"P Keskinen","year":"1997","unstructured":"Keskinen, P., Ronni, T., Matikainen, S., Lehtonen, A. & Julkunen, I. Regulation of HLA class I and II expression by interferons and influenza A virus in human peripheral blood mononuclear cells. Immunology 91, 421\u2013429 (1997).","journal-title":"Immunology"},{"key":"1113_CR34","doi-asserted-by":"publisher","first-page":"e63430","DOI":"10.7554\/eLife.63430","volume":"9","author":"M Gregorova","year":"2020","unstructured":"Gregorova, M. et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. Elife 9, e63430 (2020).","journal-title":"Elife"},{"key":"1113_CR35","doi-asserted-by":"publisher","first-page":"24384","DOI":"10.1073\/pnas.2015486117","volume":"117","author":"JR Habel","year":"2020","unstructured":"Habel, J. R. et al. Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proc. Natl Acad. Sci. USA 117, 24384\u201324391 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1113_CR36","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3389\/fimmu.2019.01844","volume":"10","author":"C Phetsouphanh","year":"2019","unstructured":"Phetsouphanh, C. et al. Maintenance of functional CD57+ cytolytic CD4+ T Cells in HIV+ Elite Controllers. Front. Immunol. 10, 1844 (2019).","journal-title":"Front. Immunol."},{"key":"1113_CR37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","volume":"93","author":"RA Lew","year":"2008","unstructured":"Lew, R. A. et al. Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp. Physiol. 93, 685\u2013693 (2008).","journal-title":"Exp. Physiol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01113-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01113-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01113-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T08:15:52Z","timestamp":1643789752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-021-01113-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1038\/s41590-021-01113-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.01.21257759","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"30 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}